Heart outcomes after drug-eluting balloon treatment for coronary blockages

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will perform a retrospective analysis of an institutional database to identify adults treated with drug-eluting balloons during coronary angioplasty from January 2010 to December 2025. Patients with incomplete post-procedural follow-up data or procedures that used other devices together with drug-eluting balloons will be excluded. Major adverse cardiovascular events (MACE) and vital status will be captured with prospective follow-up of identified patients. The analysis is single-center and based on routine clinical records from IUCPQ in Québec.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults (\>=18 years of age)
* Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
* Identified in the institutional procedure database

Exclusion Criteria:

* Incomplete or non-available data on the post-procedural clinical follow-up
* Procedures where other devices were used in combination with drug-eluting balloons.

Where it's running

• Iucpq
  Québec, Quebec, Canada Recruiting

Study contacts

• Study coordinator: Michele Jadin
• Email: michele.jadin@criucpq.ulaval.ca
• Phone: 418-6568711

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing two techniques for treating complex coronary bifurcation lesions

  This study is testing two different ways to treat complex heart artery blockages to see which one helps patients feel better and have fewer heart problems after the procedure.

  Recruiting at 2 sites Istanbul Mehmet Akif Ersoy Educational and Training Hospital · Istanbul and 1 other locations · NCT06931574

• Red grape juice and metabolism in men with coronary disease

  Researchers will test whether daily red grape juice changes the blood metabolite profile in men with chronic coronary artery disease.

  Recruiting University of Sao Paulo General Hospital · São Paulo, São Paulo · NCT07777341

• Edoxaban vs. Apixaban in AF with CAD: Net Benefit

  This trial tests whether edoxaban-based therapy provides a similar or better overall benefit than apixaban-based therapy for stroke prevention and major bleeding in adults with atrial fibrillation and coronary artery disease.

  Recruiting Phase 4 Samsung Medical Center · Seoul · NCT07753200

• Revascularization of Calcified Coronary Arteries

  This study tests whether measuring blood flow and pressure before and after ballooning or stenting of calcified coronary arteries can help predict how well the procedure will work for adults with heart disease.

  Recruiting Aalborg University Hospital · Aalborg · NCT07724184

• OPN Balloon Use for Recanalization of Calcified Coronary Lesions

  This registry tests how the SIS-OPN balloon is used in real-world patients with calcified coronary disease who have undergone PCI in North America.

  Recruiting Minneapolis Heart Institute Foundation · Minneapolis, Minnesota · NCT07646444

• Pulse IVL to open calcified coronary vessels in CAD

  A small, early feasibility study tests the Pulse Intravascular Lithotripsy system in adults with coronary artery disease to see if it can safely open calcified arteries and improve vessel compliance.

  Recruiting at 4 sites Amplitude Vascular Systems, Inc. · Sydney, New South Wales and 3 other locations · NCT07510438

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.